Correlation Between Nexam Chemical and AlzeCure Pharma

Can any of the company-specific risk be diversified away by investing in both Nexam Chemical and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexam Chemical and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nexam Chemical Holding and AlzeCure Pharma, you can compare the effects of market volatilities on Nexam Chemical and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexam Chemical with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexam Chemical and AlzeCure Pharma.

Diversification Opportunities for Nexam Chemical and AlzeCure Pharma

-0.78

Correlation Coefficient

Nexam Chemical  AlzeCure Pharma

Pay attention - limited upside

The 3 months correlation between Nexam and AlzeCure is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Nexam Chemical Holding and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and Nexam Chemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexam Chemical Holding are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of Nexam Chemical i.e., Nexam Chemical and AlzeCure Pharma go up and down completely randomly.

Pair Corralation between Nexam Chemical and AlzeCure Pharma

Assuming the 90 days trading horizon Nexam Chemical Holding is expected to under-perform the AlzeCure Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Nexam Chemical Holding is 2.72 times less risky than AlzeCure Pharma. The stock trades about -0.08 of its potential returns per unit of risk. The AlzeCure Pharma is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  117.00  in AlzeCure Pharma on December 24, 2024 and sell it today you would earn a total of  163.00  from holding AlzeCure Pharma or generate 139.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nexam Chemical Holding  vs.  AlzeCure Pharma

Nexam Chemical Holding

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nexam Chemical Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AlzeCure Pharma

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in AlzeCure Pharma are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, AlzeCure Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nexam Chemical and AlzeCure Pharma

The main advantage of trading using opposite Nexam Chemical and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexam Chemical position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.

The idea behind Nexam Chemical Holding and AlzeCure Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.